1-6 of 6
Amit Chhabra
Close
Sort by
Journal Articles

Health-Related Quality of Life in Adults with Hemophilia B after Receiving Gene Therapy with Fidanacogene Elaparvovec

Sylvia von Mackensen, Jonathan M. Ducore, Lindsey A. George, Adam Giermasz, Catherine McGuinn, John E. J. Rasko, Ben J Samelson-Jones, Spencer K. Sullivan, Jerome M. Teitel, Amit Chhabra, Annie F. Fang, Amanda O'Brien, Frank Plonski, Jeremy Rupon, Lynne Smith, Ian Winburn
Journal: Blood
Blood (2023) 142 (Supplement 1): 3628.
https://doi.org/10.1182/blood-2023-179431
Published: 2023
Journal Articles

A Retrospective Cohort Study of Switching Patterns Among Hemophilia a and B Patients Using Optum Electronic Health Records (EHR) Database in the United States (US)

Yun Gu, Kui Huang, Xunming Sun, Xiaofeng Zhou, Rongjun Shen, Lisa J. Young, Amit Chhabra, Gregory Di Russo, Jeremy Rupon, Ian Winburn
Journal: Blood
Blood (2022) 140 (Supplement 1): 5603–5605.
https://doi.org/10.1182/blood-2022-163569
Published: 2022
Journal Articles

Global Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Serotypes of Relevance to Gene Therapy

Professor John Rasko, George Bashirians, Christos Petropoulos, Terri Wrin, Yuvika Paliwal, Suryanarayan Somanathan, Michelle Casey, Candida da Fonseca Pereira, Ian Winburn, Amit Chhabra
Journal: Blood
Blood (2022) 140 (Supplement 1): 10668–10670.
https://doi.org/10.1182/blood-2022-158305
Published: 2022
Journal Articles

Follow-up of More Than 5 Years in a Cohort of Patients with Hemophilia B Treated with Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy

Ben J. Samelson-Jones, Spencer K. Sullivan, John E.J. Rasko, Adam Giermasz, Lindsey A. George, Jonathan M. Ducore, Jerome M. Teitel, Catherine E. McGuinn, Amanda O'Brien, Ian Winburn, Lynne M Smith, Amit Chhabra, Jeremy Rupon
Journal: Blood
Blood (2021) 138 (Supplement 1): 3975.
https://doi.org/10.1182/blood-2021-150541
Published: 2021
Journal Articles

Analysis of US Claims Real World Data of Hemophilia a & B Patients: Units Dispensed & Expenditures Associated with Utilization of and Switching from Standard to Extended Half-Life Factor Products

Bartholomew J. Tortella, MD MBA, Amit Chhabra, MBBS, MPH, José Alvir, DrPH, Emily R. Rubinstein, MPH, Lisa J. Young, MSc, Patrick F. Fogarty, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3508.
https://doi.org/10.1182/blood-2018-99-119133
Published: 2018
Journal Articles

Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US

Amit Chhabra, MBBS, MPH, José Alvir, DrPH, Dean Spurden, PhD, Patrick F. Fogarty, MD, Bartholomew Tortella, MDMBA, Margaret McDonald, PhD, Andreas M Pleil, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2351.
https://doi.org/10.1182/blood.V130.Suppl_1.2351.2351
Published: 2017